University of Iowa researchers received federal funding from the NIH to advance an antioxidant -based technology that may ...

InVision Eye Care is using a virtual reality-based patient education tool to show patients with cataracts what their vision ...

Giant cell arteritis, long known by its more familiar name, temporal arteritis, is the most common vasculitis in adults over ...

Zero Blind Babies uses wide-field retinal imaging and telemedicine to expand ROP screening across Ghana, Ethiopia, Tanzania, ...

Dante Pieramici, MD, on how a sustained-release TKI dosed every six months could cut clinic volume, ease treatment burden, ...

The phase 3 study is the first pivotal gene therapy trial to evaluate OCU410 in patients with GA secondary to dAMD. The FDA ...

Declining estrogen and androgen levels can disrupt lacrimal and meibomian gland function, driving evaporative dry eye during ...

Yehia Hashad, MD, discusses BL1332's phase 1b pain data and what's ahead as the TRPV1 antagonist enters phase 2 in patients ...

A priority review in Stargardt disease, two pivotal-trial milestones, an emerging bispecific for wet AMD, and new diagnostic ...

Jonathan Gloth, MD, explains how MK-8748's dual Tie2 agonist/VEGF inhibitor mechanism differs from VEGF blockade alone, and ...

Jonathan Gloth, MD, discusses how a dual Tie2/VEGF mechanism could reduce injection burden and the consequences of missed ...

John W. Kitchens, MD, discusses patient selection for geographic atrophy treatment, counseling approaches, and emerging ...